Addressing scale-up challenges through technological innovation for cost-effective vaccine development
Deep dive into scaling viral manufacturing cost-effectively
Learn moreDeep dive into scaling viral manufacturing cost-effectively
Learn moreMeet capacity challenges growing a suspension HEK293 cell line in serum-free conditions to produce an AAV-2 product in high quantities with a scale-X™ fixed-bed bioreactor
Learn moreStreamlined bioreactor-to-bioreactor seed train
Learn moreHighly productive lentivirus manufacture using the scale-X™ technology
Learn moreAddressing biomanufacturing challenges through flexible platform design for both adherent & suspension cell lines
Learn more